NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/28/2026
Back to search
Official data from USPTO
RAYZEBIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
04/28/2026
Trademark type
Combined
Nice classes
5
Filing date
01/27/2022
Registration date
04/28/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/28/2026
Last transaction
04/28/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/31/2020
First use in commerce
12/31/2020
Drawing code
3
Owner type
03
Owner location
San Diego, CA, US
Examiner
RIOS, SASHA BOSHART
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of wording "RAYZEBIO" in stylized font, where the "R" and the "B" are in capital letters, with the remaining letters in lowercase, and the letter "A" in a slightly different font than the remaining font, and a design of a shooting star above the wording consisting of a line curving downwards, starting from above the letter "A", and ending at the punctuation in the letter "I", which is represented as a star.
Holders and representatives
Holders
RayzeBio, Inc.
Representatives
Xiomara Triana Bristol-Myers Squibb Company
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
therapeutic radiopharmaceutical preparations for the treatment of cancer and solid tumors; diagnostic radiopharmaceutical preparations; diagnostic agentspreparations and substances for medical purposes; radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; radio-isotope markers for therapeutic or diagnostic use
Publications
History of USPTO decisions and trademark events.
46 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/28/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/07/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/07/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/12/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/12/2026
EX5G
SOU EXTENSION 5 GRANTED
03/12/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/11/2026
IUAF
USE AMENDMENT FILED
09/03/2025
EISU
TEAS STATEMENT OF USE RECEIVED
09/03/2025
EXT5
SOU EXTENSION 5 FILED
09/02/2025
EEXT
SOU TEAS EXTENSION RECEIVED
06/02/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/08/2025
EX4G
SOU EXTENSION 4 GRANTED
03/07/2025
EXT4
SOU EXTENSION 4 FILED
03/07/2025
EEXT
SOU TEAS EXTENSION RECEIVED
03/07/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/23/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/23/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/23/2024
EX3G
SOU EXTENSION 3 GRANTED
08/17/2024
EXT3
SOU EXTENSION 3 FILED
08/17/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/16/2024
EEXT
SOU TEAS EXTENSION RECEIVED
08/16/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/16/2024
EX2G
SOU EXTENSION 2 GRANTED
02/15/2024
EXT2
SOU EXTENSION 2 FILED
02/15/2024
EEXT
SOU TEAS EXTENSION RECEIVED
02/15/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/31/2023
EX1G
SOU EXTENSION 1 GRANTED
08/29/2023
EXT1
SOU EXTENSION 1 FILED
08/29/2023
EEXT
SOU TEAS EXTENSION RECEIVED
08/29/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/07/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/10/2023
PUBO
PUBLISHED FOR OPPOSITION
01/10/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/21/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/07/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/17/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/17/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/17/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/09/2022
GNRT
NON-FINAL ACTION E-MAILED
11/09/2022
CNRT
NON-FINAL ACTION WRITTEN
11/09/2022
DOCK
ASSIGNED TO EXAMINER
11/07/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/02/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/01/2022
NWAP
NEW APPLICATION ENTERED
01/31/2022
Continuous trademark protection
Get notified about every new filing that threatens RAYZEBIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.